5 Amazing Facts About the Gaming Industry
7 4 2021
“At the University of Bolton, we take great pride in providing a quality, supportive learning environment for our students.”
Professor George E Holmes DL | President & Vice Chancellor
“...tutors are very supportive and you’re not just a student ID number, at this university you are an individual with a name.”
Ellisse Vernon | BSc (Hons) Adult Nursing
Back to menu
Back to menu
Categories: Clinical and Biomedical Sciences, Undergradute
A simple blood test could be all it takes to identify people in the early stages of Alzheimer's disease, before symptoms are even present, according to a new study in the USA.
Alzheimer's disease is a major cause of dementia that destroys brain cells and tissue. As the brain damage spreads, it leads to symptoms such as confusion, memory loss, and diminishing the capacity to function. Eventually, the person can no longer lead an independent life. The results of the study, published in Journal Neurology, showcase a potential breakthrough in the fight against the disease.
“Right now, we screen people for clinical trials with brain scans, which is time-consuming and expensive, and enrolling participants takes years,” said Senior Author Randall Bateman, a leading professor of neurology.
“But with a blood test, we could potentially screen thousands of people a month. That means we can more efficiently enrol participants in clinical trials, which will help us find treatments faster, and could have an enormous impact on the cost of the disease as well as the human suffering that goes with it.”